Diabetes Research Center, Beijing University of Chinese Medicine, Beijing 100029, China.
Fraser Lab for Diabetes Research, McGill University Health Center, Montreal, Canada H3A 1A1.
Evid Based Complement Alternat Med. 2013;2013:636053. doi: 10.1155/2013/636053. Epub 2013 Nov 24.
Turmeric (Curcuma longa), a rhizomatous herbaceous perennial plant of the ginger family, has been used for the treatment of diabetes in Ayurvedic and traditional Chinese medicine. The active component of turmeric, curcumin, has caught attention as a potential treatment for diabetes and its complications primarily because it is a relatively safe and inexpensive drug that reduces glycemia and hyperlipidemia in rodent models of diabetes. Here, we review the recent literature on the applications of curcumin for glycemia and diabetes-related liver disorders, adipocyte dysfunction, neuropathy, nephropathy, vascular diseases, pancreatic disorders, and other complications, and we also discuss its antioxidant and anti-inflammatory properties. The applications of additional curcuminoid compounds for diabetes prevention and treatment are also included in this paper. Finally, we mention the approaches that are currently being sought to generate a "super curcumin" through improvement of the bioavailability to bring this promising natural product to the forefront of diabetes therapeutics.
姜黄(Curcuma longa),一种姜科的根茎状多年生草本植物,在印度阿育吠陀和中医中被用于治疗糖尿病。姜黄的活性成分姜黄素作为一种治疗糖尿病及其并发症的潜在药物引起了人们的关注,主要是因为它是一种相对安全且廉价的药物,可降低糖尿病啮齿动物模型中的血糖和血脂。在这里,我们回顾了最近关于姜黄素在血糖和与糖尿病相关的肝脏疾病、脂肪细胞功能障碍、神经病、肾病、血管疾病、胰腺疾病和其他并发症中的应用的文献,并讨论了其抗氧化和抗炎特性。本文还包括了其他姜黄素化合物在糖尿病预防和治疗中的应用。最后,我们提到了目前正在寻求通过提高生物利用度来生成“超级姜黄素”的方法,以使这种有前途的天然产物成为糖尿病治疗的前沿。